IBT Staff Reporter

72961-72990 (out of 154943)

Report urges U.S. open door to China investment flood

Tens of billions of dollars of Chinese investment could flood into the United States in the next decade, creating a multitude of American jobs if officials do not succumb to a political backlash and throw up barriers, according to a report released on Wednesday.

Oil down ahead of U.S. inventory data

Crude oil futures slipped again on Wednesday in volatile trade ahead of the release of weekly U.S. oil inventory data expecting to show an increase in crude stockpiles later in the day.

Stock futures dip ahead of ADP jobs report

U.S. stock index futures edged lower on Wednesday as investors awaited data on the services industry and labor market for insight into the health of the economic recovery.

BNP's bumper Q1 sets high bar for rivals

BNP Paribas, France's biggest listed bank, beat first-quarter forecasts, driven by strong retail growth and resilient investment banking that bolstered investor confidence and set a high bar for rivals.

Portugal faces recession, opposition meets lenders

Portugal's main opposition party met European and IMF officials on Wednesday and said they would consider whether to back a 78-billion-euro bailout after a source said the terms would propel the economy into two years of recession.

BNP retail boosts bumper Q1, shares rise

BNP Paribas , France's biggest listed bank, beat forecasts for first-quarter revenue and earnings, driven by strong retail growth and resilient investment banking that bolstered investor confidence.

Portugal bailout agreed but political support needed

Portugal reached a deal with the European Union and the IMF Tuesday on a 78 billion euro 3-year bailout, the third euro zone member to do so after Greece and Ireland, caretaker Prime Minister Jose Socrates said.

StanChart cuts staff to combat cost pressures

Standard Chartered Plc said it had cut 800 jobs this year to restrain rising costs after making record first quarter profits and revenue on the back of strong Asian markets like India and Hong Kong.

FDA OKs new treatment for Type 2 diabetes

The U.S. Food and Drug Administration (FDA) approved Tradjenta (linagliptin) tablets, used with diet and exercise, to improve blood glucose control in adults with Type 2 diabetes. Tradjenta is marketed by Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Conn., and Indianapolis-based Eli Lilly Co.

Stocks dip; Portugal yields fall after bailout

World stocks fell further from last week's three-year high on Wednesday as falling commodity prices and concerns about signs of economic slowdown in China prompted investors to scale back their risky positions.

Pages